According to Fortune Business Insights, the global genomics market was valued at USD 34.23 billion in 2025 and is projected to grow from USD 38.24 billion in 2026 to USD 99.26 billion by 2034, exhibiting a CAGR of 12.66% during the forecast period. North America dominated the genomics market with a market share of 43.04% in 2025.
The market is witnessing significant development due to the increasing adoption of genomic technologies across healthcare, pharmaceutical research, biotechnology, and academic institutions. Genomics involves the study of an organism's complete genetic material, including its structure, function, mapping, and analysis. These technologies enable researchers and healthcare professionals to understand genetic variations, identify disease-associated genes, and develop more targeted approaches to disease prevention, diagnosis, and treatment. Growing interest in precision medicine, advancements in sequencing technologies, and increasing investments in genetic research are supporting the expansion of the genomics market. Furthermore, the integration of computational tools, bioinformatics, and artificial intelligence is improving the interpretation of complex genomic information and strengthening research capabilities.
Continue reading for more details:
https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941
The genomics market is segmented based on technology, application, and end user. By technology, the market is categorized into polymerase chain reaction (PCR), sequencing, microarray, nucleic acid extraction and purification, and other technologies. Sequencing represents an important technology segment due to its extensive applications in genetic analysis, disease research, and personalized medicine. Next-generation sequencing has improved the ability of researchers to analyze genetic information efficiently and identify variations associated with different diseases. PCR technology also holds a significant position because it enables the amplification and detection of specific DNA sequences. Microarray technologies support gene expression analysis and genetic variation studies, while nucleic acid extraction and purification technologies provide essential preparation procedures for genomic testing and research.
Based on application, the market is divided into diagnostics, drug discovery and development, personalized medicine, agriculture and animal research, and other applications. Diagnostics represents a major application area as genomic technologies are increasingly used to identify inherited disorders, infectious diseases, and various cancer-related genetic alterations. Drug discovery and development is another important application, as pharmaceutical and biotechnology companies use genomic information to understand disease mechanisms, identify therapeutic targets, and evaluate potential drug candidates. Personalized medicine is gaining attention because genomic analysis helps healthcare providers understand individual genetic characteristics and support more tailored treatment approaches. Additionally, genomics is increasingly being applied in agricultural research to improve crop characteristics, enhance productivity, and support the development of disease-resistant plant varieties.
By end user, the market is categorized into pharmaceutical and biotechnology companies, hospitals and clinics, academic and research institutions, and other end users. Pharmaceutical and biotechnology companies represent an important customer segment because they increasingly incorporate genomic technologies into drug discovery, clinical research, and therapeutic development. Hospitals and clinics are adopting genomic testing to support disease diagnosis, genetic screening, and personalized treatment decisions. Academic and research institutions also contribute to market development through extensive investigations into genetics, molecular biology, inherited diseases, and emerging genomic technologies.